Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

MC-1R is present in skin cells and may help reduce inflammation.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

The ACE1 gene variant doesn't affect long-COVID symptoms.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

Integrating biological networks improves drug repurposing and ADR prediction.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

17β-estradiol can reduce inflammation in the skin.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Activated ras can protect kidney cells from a certain substance that causes cell death.

The combination of encorafenib and binimetinib caused few skin issues.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Ruxolitinib can cause a delayed skin reaction on the nose.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Immunoadsorption successfully treated a man's resistant polymyositis.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

DNCB helps regrow hair in alopecia areata patients, but safer alternatives are needed.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Rituximab improved her dermatomyositis better than usual treatments.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

RCDP NCs are promising anti-aging cosmetic ingredients that improve skin health by reducing oxidative stress and enhancing cell function.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.